Condition: Idiopathic Pulmonary Fibrosis · Sponsor: University of Virginia
Idiopathic pulmonary fibrosis has a poor prognosis with limited treatment options. The Investigator hypothesize hyperpolarized Xe129-MRI can be performed in patients with IPF and repeated over time which will detect deficiencies related to perfusion in the lung.
This description comes directly from the study's public registry record.
Roselove Asare, MA · 4342436074 · rnn3b@uvahealth.org
Carol Bampoe, BS
Always discuss trial participation with your own doctor first.
| Snyder Building 480 Ray C. Hunt Drive | Charlottesville, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06853145